The clinical and physiological spectrum of interferon‐alpha induced thyroiditis: Toward a new classification

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Hepatology

• Publication date

  2006-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.21146PMID 16557537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Graves' disease.

  2007cited by this paper
• Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures.

  2005cited by this paper
• Hashimoto Encephalopathy with Pegylated Interferon Alfa-2b and Ribavirin

  2005cited by this paper
• Autoantibodies and hepatitis C virus genotypes in chronic hepatitis C patients in Estonia.

  2005cited by this paper
• Thyrotropin receptor-associated diseases: from adenomata to Graves disease.

  2005cited by this paper
• Innate and acquired immune system in patients developing interferon-alpha-related autoimmune thyroiditis: a prospective study.

  2005cited by this paper
• Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

  2005cited by this paper
• Hepatitis C and thyroid autoimmunity: is there a link?

  2004cited by this paper
• Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism.

  2004cited by this paper
• Thyroid disorders in chronic hepatitis C.

  2004cited by this paper
• Thyroid autoimmunity and dysfunction associated with type I interferon therapy

  2004cited by this paper
• The role of ribavirin in the combination therapy of hepatitis C virus infection.

  2004cited by this paper
• Complexity and diversity of hepatitis C virus RNA in african americans and whites: analysis of the envelope-coding domain.

  2004cited by this paper
• The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease.

  2004cited by this paper
• Arginine at position 74 of the HLA-DR β1 chain is associated with Graves' disease

  2004cited by this paper
• Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus.

  2004cited by this paper
• Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity.

  2004cited by this paper
• Ribavirin upregulates interleukin‐12 receptor and induces T cell differentiation towards type 1 in chronic hepatitis C

  2004cited by this paper
• Prevention of Autoantibody-Mediated Graves’-Like Hyperthyroidism in Mice with IL-4, a Th2 Cytokine

  2003cited by this paper
• Interferon-α and Autoimmune Thyroid Disease

  2003cited by this paper
• Autoimmune aspects of cytokine and anticytokine therapies.

  2003cited by this paper
• Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function.

  2003cited by this paper
• The Effects of Alpha Interferon on the Development of Autoimmune Thyroiditis in the NOD H2h4 Mouse

  2003cited by this paper
• Comparative study of hepatitis C virus genotypes 1 and 3 in Salvador, Bahia Brazil.

  2003cited by this paper
• Side effects of therapy for chronic hepatitis C.

  2003cited by this paper
• Interferons: mechanisms of action and clinical applications

  2003cited by this paper
• Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection

  2003cited by this paper
• Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease

  2003cited by this paper
• Interferon-alpha and autoimmune thyroid disease.

  2003cited by this paper
• Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families.

  2003cited by this paper
• Critical Role for STAT4 Activation by Type 1 Interferons in the Interferon-γ Response to Viral Infection

  2002cited by this paper
• Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

  2002cited by this paper
• The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism.

  2002cited by this paper
• Is the IFN‐alpha‐related thyroid autoimmunity an immunologically heterogeneous disease?

  2002cited by this paper
• Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: A prospective study

  2002cited by this paper
• Graves' ophthalmopathy associated with interferon-alpha treatment for hepatitis C.

  2002cited by this paper
• Recombinant alfa‐interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C

  2002cited by this paper
• Thyrotoxicosis induced by alpha‐interferon therapy in chronic viral hepatitis

  2002cited by this paper
• Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy

  2002cited by this paper
• Graves' Ophthalmopathy Associated with Interferon-α Treatment for Hepatitis C

  2002cited by this paper
• Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

  2002cited by this paper
• CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production.

  2001cited by this paper
• Thyroid gland dysfunctions during antiviral therapy of chronic hepatitis C.

  2001cited by this paper
• Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.

  2001cited by this paper
• Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.

  2001cited by this paper
• Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text

  2001cited by this paper
• Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities.

  2001cited by this paper
• Subacute thyroiditis during treatment with combination therapy (interferon plus ribavirin) for hepatitis C virus

  2000cited by this paper
• Graves' disease.

  2000cited by this paper
• Biologic Responses to IFN-α Administration in Humans

  2000cited by this paper
• Management of Graves' ophthalmopathy: reality and perspectives.

  2000cited by this paper
• Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study.

  2000cited by this paper
• Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.

  2000cited by this paper
• Biologic responses to IFN-alpha administration in humans.

  2000cited by this paper
• Type I interferons and T helper development.

  2000cited by this paper
• Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease

  1999cited by this paper
• Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study

  1999cited by this paper
• Contact hypersensitivity responses following ribavirin treatment in vivo are influenced by type 1 cytokine polarization, regulation of IL-10 expression, and costimulatory signaling.

  1999cited by this paper
• Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

  1999cited by this paper
• Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: Results of a community-based study in northwestern Sardinia

  1999cited by this paper
• Expression of ICAM-1, B7.1 and TPO on human thyrocytes induced by IFN-alpha.

  1999cited by this paper
• HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.

  1999cited by this paper
• The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus.

  1999cited by this paper
• Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.

  1998cited by this paper
• Linkage analysis of candidate genes in autoimmune thyroid disease. II. Selected gender-related genes and the X-chromosome. International Consortium for the Genetics of Autoimmune Thyroid Disease.

  1998cited by this paper
• The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses.

  1998cited by this paper
• Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.

  1998cited by this paper
• Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature.

  1997cited by this paper
• Hepatitis C Serotypes in Nonalcoholic and Alcoholic Patients

  1997cited by this paper
• New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine.

  1997cited by this paper
• Epidemiology and estimated population burden of selected autoimmune diseases in the United States.

  1997cited by this paper
• Interferon-α Induced Thyroid Dysfunction: Three Clinical Presentations and a Review of the Literature

  1997cited by this paper
• Effects of interferon‐alpha (IFN‐α) administration on leucocytes in healthy humans

  1997cited by this paper
• Failure to Find an Association Between Hepatitis C Virus and Thyroid Autoimmunity

  1997cited by this paper
• Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.

  1996cited by this paper
• Side effects of high-dose interferon therapy for chronic hepatitis C.

  1996cited by this paper
• Chronic autoimmune thyroiditis.

  1996cited by this paper
• Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon‐α therapy

  1996cited by this paper
• Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis

  1996cited by this paper
• [Natural history of dysthyroidism during interferon treatment of chronic hepatitis C].

  1996cited by this paper
• Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis.

  1995cited by this paper
• Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.

  1995cited by this paper
• The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey

  1995cited by this paper
• Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.

  1995cited by this paper
• CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population.

  1995cited by this paper
• T helper cell subsets in insulin-dependent diabetes.

  1995cited by this paper
• Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection.

  1995cited by this paper
• Cytokine therapeutics: lessons from interferon alpha.

  1994cited by this paper
• The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C.

  1994cited by this paper
• Latent autoimmune thyroid disease in patients with chronic HCV hepatitis.

  1993cited by this paper
• Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy.

  1993cited by this paper
• High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy

  1993cited by this paper
• Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C

  1993cited by this paper
• Infection, thyroid disease, and autoimmunity.

  1993cited by this paper
• Reversible inhibition by interferons alpha and beta of 125I incorporation and thyroid hormone release by human thyroid follicles in vitro.

  1993cited by this paper
• Pathogenesis of Graves' ophthalmopathy.

  1993cited by this paper
• Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa.

  1992cited by this paper
• Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and Interleukin 2

  1991cited by this paper
• The interferons. Mechanisms of action and clinical applications.

  1991cited by this paper
• Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture.

  1990cited by this paper

• Improving the management of Polycythemia Vera patients eligible for cytoreduction: report of a multidisciplinary advisory board

  2025influential citation
• Management of common autoimmune diseases in patients with myeloproliferative neoplasms treated with pegylated interferon alfa—case report, review of the literature and multidisciplinary clinical practice recommendations

  2025cites this paper
• Shear-Wave Elastography in Diffuse Thyroid Diseases

  2023cites this paper
• Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha

  2023cites this paper
• Silent Thyroiditis Associated with Ropeginterferon α-2b in a Patient with Polycythemia Vera

  2023cites this paper
• The influence of vitamin D and iron on thyroid function and thyroid autoimmunity

  2022cites this paper
• Ulcerative colitis triggered by pegylated interferon alpha-2b in a patient with chronic hepatitis B: A case report and literature review

  2021cites this paper
• Клинические рекомендации «Острые и хронические тиреоидиты (исключая аутоиммунный тиреоидит)»

  2021cites this paper
• Type I interferon detection in autoimmune diseases: challenges and clinical applications

  2021cites this paper
• Endocrinopathies in Aicardi Goutières syndrome—A descriptive case series

  2020cites this paper
• Thyroid Dysfunction Related to the Antiangiogenic VEGFR2-Binding Monoclonal Antibody Ramucirumab: A Series of 14 Cases and a Descriptive Study.

  2020cites this paper
• Safety of systemic treatments for Behçet’s syndrome

  2020cites this paper
• Hashimoto’s thyroiditis might increase polycystic ovary syndrome and associated comorbidities risks in Asia

  2020cites this paper
• Anticancer Drug-induced Thyroid Dysfunction.

  2020influential citation
• Strategies for treating and managing chronic hepatitis C in children in the direct-acting antiviral era

  2020cites this paper
• Thyroid dysfunction among chronic hepatitis C patients and its relation to Interferon therapy

  2020cites this paper
• Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV-HIV co-infected patients before and after interferon alpha therapy: A prospective study.

  2020cites this paper
• Associations between serum levels of thyroid stimulating hormone (TSH), free thyroxine (fT4), free triiodothyronine (fT3) and clinical symptoms in patients diagnosed with Hashimoto’s thyroiditis

  2020cites this paper
• Endocrine Toxicities of Immunotherapy

  2020cites this paper
• [Thyroiditis: What's new in 2019?]

  2020cites this paper
• Classification of Thyroid Diseases

  2019cites this paper
• Hypothyroidism and Hashimoto’s Thyroiditis: Mechanisms, Diagnosis, Neuropsychological Phenotypes, and Treatments

  2019cites this paper
• HCV Extrahepatic Manifestations

  2019cites this paper
• Immunological Mechanisms of Autoimmune Thyroid Diseases: A Shift in The Traditional TH1/TH2 Paradigm

  2019cites this paper
• IRF7 Gene Variations Confer Susceptibility to Autoimmune Thyroid Diseases and Graves' Ophthalmopathy

  2019cites this paper
• Interferon alpha: The key trigger of type 1 diabetes.

  2018cites this paper
• Interferon-&agr; Triggers Autoimmune Thyroid Diseases via Lysosomal-Dependent Degradation of Thyroglobulin

  2018cites this paper
• LABORATORY EVIDENCE OF AUTOIMMUNITY IN HCV INFECTED PATIENTS AFTER INTERFERON TREATMENT

  2018cites this paper
• Chapter 5 Interferon-Induced Thrombotic Microangiopathy

  2018cites this paper
• Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies

  2018cites this paper
• Thyroid dysfunctions secondary to cancer immunotherapy

  2018cites this paper
• Interferon-Induced Thrombotic Microangiopathy

  2018cites this paper
• Safety of Interferon Alpha-2a in Patients with Severe Ophthalmic Behçet’s Disease: Response to Bielefeld et al.’s Letter

  2018cites this paper
• Subacute Thyroiditis Associated with Interferon Therapy of Polycythemia Vera : Report of a Case and Literatures Review

  2017influential citation
• Interferon alpha-induced non-immune thyrotoxicosis treated by plasmapheresis

  2017cites this paper
• Antibodies to extracellular regions of G protein-coupled receptors and receptor tyrosine kinases as one of the causes of autoimmune diseases

  2017cites this paper
• Leveraging the immune system to treat advanced thyroid cancers.

  2017cites this paper
• Thyroid Autoimmunity and Function after Treatment with Biological Antirheumatic Agents in Rheumatoid Arthritis

  2017cites this paper
• Drug-induced hypothyroidism.

  2017cites this paper
• Interferon induced thrombotic microangiopathy (TMA): Analysis and concise review.

  2017cites this paper
• Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity

  2017cites this paper
• Additive Value of Thyroid Uptake and Scintigraphy in Diagnosis of Short-Term Thyroid Dysfunction in Hepatitis C Patients Treated With Interferon-α Younis , J 1

  2017cites this paper
• Recombinant Interferon Alpha-2b is a High-Affinity Antigen for Type 1 Diabetes Autoantibodies.

  2017cites this paper
• Immunopathology of the Endocrine System

  2017cites this paper
• Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease

  2017cites this paper
• 真性红细胞增多症患者干扰素治疗中合并亚急性甲状腺炎一例报告并文献复习 Subacute Thyroiditis Associated with Interferon Therapy of Polycythemia Vera: Report of a Case and Literatures Review

  2017cites this paper
• Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.

  2017cites this paper
• Evaluation of Triiodothyronine ( T 3 ) and Lipid Peroxidation in Hepatitis C Patients Receiving Interferon and Ribavirin

  2017cites this paper
• Retraction notice

  2017cites this paper
• Thyroiditis During Pegylated Interferon Therapy and HbsAg Seroconvertion after the Treatment

  2016cites this paper
• Thyroid Dysfunction in Chronic Hepatitis C Patients Treated with the Combined Pegylated Interferon-Ribavirin Therapy

  2016cites this paper
• Prevalence of thyroid disorders in hepatitis C virus positive patients on interferon and antiviral therapy

  2016influential citation
• Thyroid dysfunction in chronic viral hepatitis [B and C]; An Egyptian pilot study

  2016cites this paper
• KASL clinical practice guidelines: management of hepatitis C

  2016cites this paper
• The Effectiveness of Nursing Intervention Program on Emotional Distress, Self-Efficacy, and Liver Enzymes Among Hepatitis C Virus Patients Undergoing Antiviral Treatment Therapy (Sovaldi Medication)

  2016cites this paper
• Asthma: On the Rise

  2015cites this paper
• Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10.

  2015cites this paper
• Endocrine manifestations of chronic HCV infection.

  2015cites this paper
• Increased risk of thyroid autoimmunity in rheumatoid arthritis

  2015cites this paper
• Unique side effects of interferon.

  2015cites this paper
• Association of IRF8 gene polymorphisms with autoimmune thyroid disease

  2015cites this paper
• Autoantibodies in chronic hepatitis C: A clinical perspective.

  2015cites this paper
• Increased binding of circulating systemic lupus erythematosus autoantibodies to recombinant interferon alpha 2b

  2015influential citation
• Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin.

  2015influential citation
• Thyroid-specific changes following treatment with biological therapies in patients with rheumatic diseases

  2015cites this paper
• Clinical Value of Thyrotropin Receptor Antibodies for the Differential Diagnosis of Interferon Induced Thyroiditis.

  2015cites this paper
• Disfunção tireoidiana e sua associação com anticorpos não órgão específico (NOSAs) em portadores de hepatite C Thyroid dysfunction and its association with non-organ-specific antibodies (NOSAs) in hepatitis C carriers

  2015cites this paper
• LE CAS CLINIQUE DU MOIS Hyperthyroïdie induite par interféron alpha : rapport d'un cas et revue de la littérature

  2015cites this paper
• Interferon-Alpha Induced Severe Hypothyroidism Followed by Graves’ Disease in a Patient Infected with Hepatitis C Virus

  2015cites this paper
• Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?

  2014cites this paper
• KASL clinical practice guidelines: Management of Hepatitis C

  2014cites this paper
• Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection

  2014cites this paper
• Genetic–epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity

  2014cites this paper
• Beeinflussung der Schilddrüsenfunktion durch Medikamente

  2014cites this paper
• Kronik hepatit C genotip 1 ve 4 hastaların tedavisi sırasında tiroid bozuklukları prevalansı ve tiroid profili ile karaciğer enzimleri, serum activin-A ve follistatin arasındaki ilişki

  2014cites this paper
• ASSOCIATION BETWEEN CRYOGLOBULINEMIA AND THYROID DYSFUNCTION IN HEPATITIS C CARRIERS

  2014cites this paper
• Hashimoto thyroiditis: clinical and diagnostic criteria.

  2014cites this paper
• Conséquences hépatiques des endocrinopathies et retentissement endocrinologique de l’insuffisance hépatique

  2014cites this paper
• Increased Serum Type I Interferon Activity in Organ-Specific Autoimmune Disorders: Clinical, Imaging, and Serological Associations

  2013cites this paper
• Thyroid disorders associated with Hepatitis C or interferon based therapies

  2013cites this paper
• Course of Graves Disease in Interferon-Treated Patients With Chronic Hepatitis C Virus Infection and in Uninfected Patients

  2013cites this paper
• Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy

  2013cites this paper
• Inflammation and Increased Myxovirus Resistance Protein A Expression in Thyroid Tissue in the Early Stages of Hashimoto's Thyroiditis

  2013cites this paper
• Frequency of Thyroid Dysfunctions during Interferon Alpha Treatment of Single and Combination Therapy in Hepatitis C Virus-Infected Patients: A Systematic Review Based Analysis

  2013cites this paper
• Patients with chronic hepatitis type C and interferon-alpha-induced hyperthyroidism in two-years clinical follow-up.

  2013cites this paper
• Pegylated interferon and ribavirin combination therapy for chronic hepatitis C associated with thyroid dysfunction

  2013cites this paper
• Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways.

  2013cites this paper
• Incidence rate of symptomatic painless thyroiditis presenting with thyrotoxicosis in Denmark as evaluated by consecutive thyroid scintigraphies

  2013cites this paper
• Regulatory T cells and other lymphocyte subpopulations in patients with melanoma developing interferon‐induced thyroiditis during high‐dose interferon‐α2b treatment

  2013cites this paper
• Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs

  2013cites this paper
• Assay of Thyroid Hormones and Related Substances

  2013cites this paper
• Chronic hepatitis C therapy: a rare complication revisited

  2013cites this paper
• Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus.

  2012cites this paper
• Extrahepatic Manifestations and Autoantibodies in Patients with Hepatitis C Virus Infection

  2012cites this paper
• Chronic hepatitis B with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy.

  2012cites this paper
• Sunitinib-Induced Autoimmune Thyroiditis in a Patient with Metastatic Renal Cell Carcinoma: A Case Report

  2012cites this paper
• Thyroid and Drugs

  2012cites this paper
• Unraveling the genetics of lymphocytic thyroiditis using the dog as a model

  2012influential citation
• Antimitochondrial antibody ‐M2 positive autoimmune hepatitis during standard of care for chronic hepatitis C

  2012cites this paper
• B-Cell-Activating Factor Affects the Occurrence of Thyroid Autoimmunity in Chronic Hepatitis C Patients Treated with Interferon Alpha

  2012cites this paper